Home Rznomics

Rznomics

In operation
PreIPO
Gene Therapy Developer
Basic
Enterprise Profile

Basic Information

Algenomics Co., Ltd. is a research company that develops gene therapies using RNA, aiming to create new biopharmaceuticals for cancer and intractable diseases with significant unmet medical needs. The company develops therapeutic products for treating various cancers, degenerative neurological disorders, and hereditary diseases, enabling doctors to treat conditions such as cancer and Alzheimer's disease.
Rznomics, Inc.
GyeonggiProvince,SouthKorea
15~50 people
January 01, 2017
rznomics@rznomics.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Biological Drug Production
Technology
Gene Technology Biotechnology
Concept
Therapeutic Products # Liver Cancer
Application Scenarios
Innovative Drugs